T40.721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter

ICD-10-CM T40.721A: Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter

ICD-10-CM code T40.721A identifies an accidental, unintentional poisoning by synthetic cannabinoids during an initial encounter. Official sources list this code within billing references and broader poisoning categories. Clinical literature notes synthetic cannabinoids can cause severe, unpredictable toxicity, while coding references distinguish this initial encounter from subsequent or sequela encounters. 3 4 5 2

Plain-language overview

Code T40.721A is an ICD-10-CM diagnosis label defined as poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter, and it appears in official billing and coding articles from the Centers for Medicare and Medicaid Services. 3 4

What this code represents

The code T40.721A represents an accidental, unintentional poisoning by synthetic cannabinoids during the initial encounter for treatment, distinguishing it from intentional self-harm, assault, or adverse effect codes within the same coding framework. 3 4 6

Coding details

A coding reference lists T40.721A alongside T40.721D for subsequent encounters and T40.721S for sequela, showing the different seventh characters used to specify the encounter type for accidental synthetic cannabinoid poisoning. 5

A CMS billing and coding article lists T40.721A for accidental poisoning and T40.722A for intentional self-poisoning by synthetic cannabinoids, while a separate coding update identifies T40.725A as the code for an adverse effect of synthetic cannabinoids. 4 6

Clinical context

Clinical literature states synthetic cannabinoids act as potent receptor agonists that produce severe, unpredictable toxicity, including marked agitation, psychosis, seizures, or dysautonomia that is out of proportion to reported cannabis use. 2

Synthetic cannabinoids marketed as K2 or Spice may provoke agitation, psychosis, seizures, acute kidney injury, myocardial infarction, and death, while routine toxicology screens frequently yield negative results for these substances. 2

Documentation considerations

Medical billing data does not include toxicology results, and many hospitals lack the capability to test for synthetic cannabinoids, which have been reported to produce higher rates of side effects and more severe side effects than cannabis plant material. 1

What the sources add

A public health study analyzed cannabinoid poisoning encounters using ICD-10-CM code T40.7X with a sixth character between 1 and 5 and a seventh character A for initial treatment, while CMS articles specifically list the exact T40.721A code for billing and coding purposes. 1 3 4

A coding industry update notes that more than a dozen new codes describe poisonings, adverse effects, and underdosing for synthetic cannabinoids, including T40.721A for accidental poisoning and T40.725A for adverse effects during an initial encounter. 6

Sources

1. Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019 — pmc.ncbi.nlm.nih.gov; accessed 2026-07-25.
2. Bookshelf — ncbi.nlm.nih.gov; accessed 2026-07-25.
3. Article - Billing and Coding: Urine Drug Testing (A56915) — cms.gov; accessed 2026-07-25.
4. Article - Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing (A57077) — cms.gov; accessed 2026-07-25.
5. ICD-10-CM 2024 | T40 - Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] — unboundmedicine.com; accessed 2026-07-25.
6. Social determinants of health finalized in CDC’s 2022 code update — ahcc.decisionhealth.com; accessed 2026-07-25.